Gradient, founded in 1985, is a seasoned environmental and risk science consulting firm based in the United States. Best known for its expertise in Toxicology, Epidemiology, and Risk Assessment, the company has built a strong reputation for helping national and global clients tackle intricate environmental and human health challenges using sound science.
Operating within the Biotechnology, Health Care, and Information Technology industries, Gradient's broad slate of services includes Chemistry/Forensics, Occupational Health & Safety, Climate Impacts, and Green Chemistry, among others. Their multifaceted approach is bolstered by capabilities in Geographic Information Systems (GIS) and Predictive Toxicology, enabling effective resolution of chemical-related issues across environments and products.
Despite its extensive portfolio and long-standing presence, Gradient has yet to disclose any investments, marking a potential avenue for investors looking to capitalize on the company’s comprehensive domain expertise and market reach.